These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prophylaxis for meningococcal disease. Artenstein MS JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581 [No Abstract] [Full Text] [Related]
4. Eradication of carriage of Neisseria meningitidis in families: a study in Brazil. Munford RS; Sussuarana de Vasconcelos ZJ; Phillips CJ; Gelli DS; Gorman GW; Risi JB; Feldman RA J Infect Dis; 1974 Jun; 129(6):644-9. PubMed ID: 4209720 [No Abstract] [Full Text] [Related]
5. [Immunoprophylaxis of meningococcal infection among the troops]. Khokhlov DT; Efimov EI Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904 [No Abstract] [Full Text] [Related]
6. The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. Beam WE; Newberg NR; Devine LF; Pierce WE; Davies JA J Infect Dis; 1971 Jul; 124(1):39-46. PubMed ID: 5004115 [No Abstract] [Full Text] [Related]
7. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Jodar L; Cartwright K; Feavers IM Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447 [No Abstract] [Full Text] [Related]
8. [Meningococcal infections. Chemical prevention or preventive vaccination]. Delville J Arch Belg Med Soc; 1973; 31(6):414-23. PubMed ID: 4592088 [No Abstract] [Full Text] [Related]
9. Microbiology. A furtive pathogen revealed. Nassif X Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929 [No Abstract] [Full Text] [Related]
10. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates. Sivonen A J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094 [No Abstract] [Full Text] [Related]
11. Meningococcal vaccines in prevention and control of meningitis. Saxena SN; Rawal IJ; Tripathi KK; Gupta P Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978 [No Abstract] [Full Text] [Related]
12. [Interpretation of the laboratory results concerning the protective effect of vaccines]. Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337 [No Abstract] [Full Text] [Related]
13. [An animal model for testing the activity of meningococcal polysaccharide vaccine]. Huet M; Suire A J Biol Stand; 1981 Jan; 9(1):67-74. PubMed ID: 6783665 [No Abstract] [Full Text] [Related]